microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway
Related Experiment Video
Updated: Dec 8, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Feng-Juan Han1, Jia Li2, Ying Shen2
1Department of Gynecology, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Objective:
Ovarian cancer (OC) has been regarded as the most malignant gynecological neoplasm and often confers grave outcomes owing to the frequent metastasis and high recurrence. A previous study has demonstrated that miR-1271-5p is implicated in OC progression, however, the possible mechanism of it remains unknown. The purpose of this investigation was to explore how miR-1271-5p regulates the progression of OC.
Methods:
Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were employed to analyze the differentially expressed miRNAs or genes as well as their corresponding prognostic values. miR-1271-5p expression in OC cells was examined by qRT-PCR. Cell counting kit 8 (CCK-8), colony formation, and transwell tests were conducted to evaluate the proliferation, migration and invasion potentials. Bioinformatics prediction and luciferase activity analysis were utilized to predict and verify the target gene of miR-1271-5p. Western blot assay was carried out to measure protein expression.
Results:
miR-1271-5p was significantly decreased in OC and its down-regulation was associated with the grave outcome of OC patients. Upregulation of miR-1271-5p inhibited cell viability, but miR-1271-5p knockdown promoted the proliferation of OC cells. TIAM1 was a direct target gene of miR-1271-5p and expressed in OC tissues at higher level. High expression of TIAM1 induced the poorer prognosis of patients with OC. Further functional analyses showed that the suppressive role of miR-1271-5p on OC cell malignant behaviors was overturned by the upregulation of TIAM1. The protein levels of Cyclin D1, HES1, NOTCH and NUMB were remarkably changed due to the abnormal expression of miR-1271-5p and TIAM1.
Conclusion:
To sum up, miR-1271-5p inhibits proliferation, invasion and migration of OC cells by directly repressing TIAM1 to inactivate the Notch signaling pathway, which provides an alternative therapeutic candidate for the advancement of OC treatment.
Insights
MicroRNA-1271-5p inhibits ovarian cancer progression by targeting TIAM1 and inactivating the Notch pathway. This finding offers a potential new therapeutic strategy for ovarian cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer (OC) is a highly malignant gynecological neoplasm with frequent metastasis and recurrence.
- MicroRNA-1271-5p (miR-1271-5p) has been linked to OC progression, but its mechanism remains unclear.
Purpose of the Study:
- To investigate the role and mechanism of miR-1271-5p in regulating ovarian cancer progression.
Main Methods:
- Analysis of Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases.
- qRT-PCR, CCK-8, colony formation, and Transwell assays to assess cell behavior.
- Bioinformatics, luciferase assays, and Western blot to identify and validate miR-1271-5p targets and pathways.
Main Results:
- miR-1271-5p was downregulated in OC and associated with poor prognosis.
- miR-1271-5p suppressed OC cell viability, proliferation, migration, and invasion.
- TIAM1 was identified as a direct target of miR-1271-5p, with high TIAM1 expression correlating with poor OC prognosis.
- Upregulation of TIAM1 counteracted the inhibitory effects of miR-1271-5p on OC cell malignancy, impacting Notch signaling pathway proteins (Cyclin D1, HES1, NOTCH, NUMB).
Conclusions:
- miR-1271-5p inhibits OC cell proliferation, invasion, and migration by directly repressing TIAM1.
- This repression inactivates the Notch signaling pathway, suggesting miR-1271-5p as a potential therapeutic target for ovarian cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

